Choosing a real-world evidence platform: what actually matters
Most RWE platforms can generate analyses. Few deliver results that can be validated, reused, and applied with confidence.
HIPAA- and GDPR-compliant trusted research environments for AI and federated analytics
Why TRE design matters in 2026
For life sciences teams, enabling research while protecting sensitive health data is a core operational requirement. Organizations must support:
- Multi-country datasets
- External collaborators, including CROs, pharmaceutical companies, and academic institutions
- AI-driven analysis on sensitive health data
- Increasing regulatory scrutiny
At the same time, regulations—especially in Europe through initiatives such as the European Health Data Space (EHDS)—are accelerating a shift away from data transfer and toward controlled access models, where data remains under the authority of its custodian.
Unlike traditional data-sharing approaches, a TRE replaces data transfer with governed access. Rather than moving patient-level datasets across borders or organizations, approved users work in controlled environments where organizations log and govern access, analysis, exports, and AI workflows. A TRE supports this shift by enabling:
- Data to remain in a controlled environment
- Access under strict conditions
- Full traceability of all activity
As a result, organizations can reduce exposure while supporting scalable, repeatable research across countries.
What HIPAA and GDPR require in practice
HIPAA and GDPR are not identical. However, they shape TRE design around three core pillars:
- Role-based access controls (RBAC)
- Strong identity management and multifactor authentication (MFA)
- Integration with enterprise identity systems
- Dataset- and project-level permissions
- Data minimization and purpose limitation
- De-identification and pseudonymization safeguards
- Restrictions on copying and exporting data
- Full audit logging of user activity
- Documented approval workflows
- Clear roles for controllers, processors, and users
- Policy-based enforcement across projects
Compliance is not a checklist — it is embedded in how access is managed, enforced, and audited.
Core capabilities of a scalable TRE
A scalable trusted research environment must support secure access, analysis, and collaboration without copying, transferring, or fragmenting data across systems. Increasingly, organizations need both centralized and federated models so they can analyze distributed data while preserving local governance and control.
Controlled data access and governance
- Access data in place without duplication
- Allow data owners to retain control
- Apply fine-grained permissions
- Maintain full auditability
Federated analytics and learning across distributed datasets
Federation allows approved users, queries, and algorithms to operate across distributed datasets without requiring every data custodian to move patient-level data into a central repository. In a TRE, organizations bring the analysis to the data. Data remains under local control while approved outputs, statistics, and model updates can be shared according to governance rules.
Federated analytics extends the value of a TRE by allowing approved queries, statistics, and AI workflows to run across distributed datasets while patient-level data remains under local control. This approach supports broader collaboration, faster feasibility assessments, and more diverse model development without increasing unnecessary data movement or cross-border transfer risk.
This capability is especially important for multi-country research, rare disease studies, oncology networks, and AI development programs, where data volume, diversity, and regulatory requirements make centralized data movement impractical.
Organizations can:
- Run approved queries across participating sites without moving patient-level data
- Support federated cohort discovery, feasibility analysis, and statistical workflows
- Enable federated learning and model validation across institutions
- Preserve local data control, provenance, and consent restrictions
- Review outputs before export to reduce privacy and compliance risk
Integrated analysis and compute
- Secure in-environment analytics
- Support for AI, machine learning, and federated learning workflows
- Analysis across multimodal data, including clinical, real-world, genomic, and imaging data
- Controlled compute environments with scalable resources for high-volume analytics
- Built-in analytics, partner applications, and bring-your-own AI models and tools
Secure collaboration across organizations
- Access for pharmaceutical companies, CROs, and academic partners
- Cross-country collaboration under shared governance
- Multi-study programs without duplication
End-to-end traceability and compliance
- Full audit trails
- Data provenance tracking for submissions
- Built-in governance workflows
- Policy enforcement by design
A TRE with these capabilities enables real-world evidence generation, AI development, and cross-border research within a secure, governed environment. By combining controlled access, federated analytics, and auditable AI workflows, organizations can expand collaboration without increasing compliance risk or compromising data control.
Looking to implement a TRE for your organization’s research? Explore BC Mosaic.
Want to understand how to evaluate and compare TREs in more detail? Read our TRE buyer’s guide.
Why cross-border research is complex
Research programs depend on data from multiple countries, healthcare systems, and custodians. As a result, organizations must navigate several challenges:
- Different data residency laws
- Local approval requirements
- Variable export rules
- Fragmented governance
Without a structured operating model, these challenges can create delays, increase compliance risk, and reduce operational efficiency. A TRE helps standardize:
- Where data is hosted
- Who can access it
- Which outputs can leave the environment
- Which approvals apply
This structure is especially important in Europe, where organizations face strict and actively enforced data protection requirements.
How this works in practice
In a recent multi-country oncology program, BC Platforms enabled the creation of AI-ready cohorts by integrating clinical and imaging data directly within a controlled hospital-based research environment.
Researchers were able to:
- Access harmonized multi-modal datasets across institutions
- Train AI models without moving patient-level data
- Maintain full auditability across countries
Data remained within hospital environments, while approved users accessed it through secure workspaces and exported only reviewed outputs.
Federated analytics and AI model development in practice
In a federated model, each participating site can retain control of its own data while approved analytics and machine learning workflows run within governed environments. Researchers can query cohort availability, run statistical analyses, and train and validate models across participating institutions without moving sensitive patient-level data outside local controls.
As a result, this model helps organizations expand AI-ready cohort discovery, model development, and external collaboration while reducing cross-border transfer risk. In addition, it supports responsible AI development by keeping model inputs, outputs, and artifacts inside controlled workspaces. Audit trails, governance review, and output controls apply throughout the research lifecycle.
Deployment flexibility: on-premises, private cloud, or cloud
TRE deployment should reflect local policy, infrastructure maturity, and data residency requirements. Some data custodians may require on-premises deployment within a hospital or research institution. Meanwhile, others may prefer private cloud or secure cloud environments to support scale, distributed collaboration, and elastic compute for AI workloads.
Regardless of the deployment model, the operating model should support these deployment patterns while maintaining consistent governance, identity management, auditability, and output controls.
Ultimately, with the right operating model, federated analytics, AI workflows, and deployment flexibility become part of a repeatable governance framework—not separate technical projects.
Example TRE use cases
Multi-country oncology research
A pharmaceutical sponsor or research network can evaluate cohort feasibility, analyze outcomes, and train AI models across hospital datasets without moving patient-level data outside local controls. This approach helps teams assess feasibility faster and collaborate across borders with less risk.
Rare disease cohort discovery
Researchers can identify eligible patient populations across multiple institutions when data is too sensitive, fragmented, or geographically distributed to centralize. This approach helps teams find viable cohorts without unnecessary data movement.
AI model training and validation
Data science teams can train, validate, and monitor models inside governed workspaces. Access controls, audit trails, and export review apply to model inputs, outputs, and artifacts throughout the model lifecycle. This approach helps teams validate models across more diverse datasets.
How to enable compliant research at scale
Effective TRE implementations focus on controlling access — not moving data. Best practices include:
- Eliminating unnecessary duplication
- Restricting uncontrolled downloads
- Enforcing project-specific permissions
- Applying export review controls
This delivers:
- Faster study setup
- Reduced compliance overhead
- Clear regulatory audit trails
- Scalable collaboration with external partners
In practice, researchers log in to a secure environment, access approved datasets, run analyses in controlled workspaces, and export results only after governance review—ensuring compliance at every step.
Common mistakes to avoid
TRE programs often fail because of operating model gaps — not technology gaps. Common pitfalls include:
- Focusing on infrastructure over governance
- Treating compliance as a checklist
- Allowing exceptions outside the environment Ignoring researcher usability
- Poorly defined export rules
- Designing for one country, then scaling later
Avoiding these early is critical for long-term success.
What a strong TRE operating model looks like
A successful TRE is defined by consistency and control:
- Standardized onboarding
- Policy-driven access
- Defined approval workflows
- Continuous monitoring and auditability
- Clear ownership across teams
Critically, it enables AI and advanced analytics without distributing sensitive data. Strong TRE operating models support model training, validation, and reuse inside governed workspaces while preserving audit trails, access controls, data provenance, and output review for regulatory-grade research at scale.
How BC Platforms supports TRE deployment
BC Platforms helps life sciences organizations design and operate trusted research environments for secure, compliant data collaboration.
Our approach combines:
- Controlled access to multi-modal clinical, real-world, genomic, and imaging data
- Integrated governance workflows
- Privacy-preserving analytics and federated data access
- Federated analytics and learning across distributed datasets
- Multi-country deployment support
- Flexible deployment across on-premises, private cloud, and secure cloud environments
- Secure user access with defined permissions and full traceability
- Integrated partner applications to enhance compute power, analytics, AI workflows, and model training within the TRE
- Support for built-in analytics or bring-your-own AI models and tools within the TRE
This enables organizations to run cross-border, research programs without increasing data exposure risk. It also gives research and AI teams a governed environment to discover cohorts, run federated analyses, train and validate models, and generate evidence across institutions while keeping sensitive data under local control.
The future of health data collaboration depends on secure, scalable operating models that protect sensitive data while accelerating research. As collaboration becomes more distributed, the organizations that succeed will combine governance, federation, AI readiness, and researcher usability in a single scalable operating model.
Do you need a TRE for cross-border research?
Build a secure, compliant environment with controlled access, federated analytics, auditable AI workflows, and no unnecessary data movement.
FAQs
A trusted research environment is a research-focused form of a secure data environment designed not only to protect sensitive data, but also to manage approvals, researcher access, audit trails, output review, and compliant collaboration across institutions. It gives approved researchers a secure, governed workspace where they can access and analyze sensitive health data without downloading or transferring patient-level datasets.
A TRE supports HIPAA and GDPR compliance by enforcing controlled access, limiting unnecessary data movement, logging user activity, applying project-specific permissions, and reviewing outputs before export. It helps organizations operationalize privacy, security, and accountability requirements across research programs.
Federated analytics allows approved queries, algorithms, and workflows to run across distributed datasets without centralizing patient-level data. In a TRE, each data custodian retains control while researchers generate approved outputs, statistics, and model updates under shared governance rules.
Yes. A TRE can support AI model training, validation, and reuse inside governed workspaces. Access controls, audit trails, governance review, and export restrictions apply to model inputs, outputs, and artifacts throughout the research lifecycle.